ULBP2 and acute myeloid leukemia: Primary AML samples taken at time of diagnosis from two different datasets express significantly higher transcript levels of NKG2D ligands MICA/MICB, ULBP1, and ULBP2 compared to healthy PBMC control (Figures 4A–C).